TARS Tarsus Pharmaceuticals, Inc.
Nasdaq · SEC CIK 1819790 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $19.96M 28 sales by 9 insiders
- Filings on record
- 278 since 2021-08-06, latest 2026-09-17 16:47
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Azamian Bobak R. | Pres, CEO, Board COB, Dir | — | $5.18M |
| LINK WILLIAM J PHD | Dir | — | $4.48M |
| Whitfield Dianne C. | CHRO | — | $2.69M |
| Lin Elizabeth Yeu | Chief Medical Off | — | $2.36M |
| Neervannan Seshadri | COO | — | $2.00M |
| Farrow Jeffrey S | See Remarks | — | $1.32M |
| Mottiwala Aziz | Chief Commercial Off | — | $892.5K |
| Wahl Bryan | GC | — | $850.4K |
| Goodrich Katherine | Dir | — | $183.4K |
| Goldberg Andrew D. | Dir | — | — |
Transactions 236
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-19 | 2024-03-18 | TARS | Wahl Bryan | GC | S - Sale+OE | $30.60 | -4,436 | 41.0K | -10% | -$135.7K |
| D | 2024-03-19 | 2024-03-15 | TARS | Wahl Bryan | GC | M - OptEx | — | +12.0K | 45.4K | +36% | — |
| D | 2024-03-19 | 2024-03-15 | TARS | Neervannan Seshadri | COO | M - OptEx | — | +13.2K | 69.6K | +23% | — |
| D | 2024-03-19 | 2024-03-18 | TARS | Neervannan Seshadri | COO | S - Sale+OE | $30.60 | -4,879 | 64.8K | -7% | -$149.3K |
| I | 2023-12-29 | 2023-12-27 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $20.22 | -8,000 | 830.1K | -1.0% | -$161.8K |
| 2023-12-22 | 2023-12-20 | TARS | Trevejo Jose M. | Chief MEDICAL Off | S - Sale | $20.00 | -2,252 | 2,251 | -50% | -$45.0K | |
| MI | 2023-12-22 | 2023-12-20 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $20.27 | -40.0K | 838.1K | -5% | -$810.6K |
| 2023-12-19 | 2023-12-15 | TARS | Goldberg Andrew D. | Dir | P - Purchase | $18.96 | +1,000 | 3,000 | +50% | +$19.0K | |
| D | 2023-12-05 | 2023-12-02 | TARS | YARNO WENDY L | Dir | M - OptEx | — | +5,000 | 7,000 | +250% | — |
| D | 2023-12-01 | 2023-11-29 | TARS | Wahl Bryan | GC | M - OptEx | $0.00 | +23.9K | 40.3K | +146% | $0 |
| D | 2023-12-01 | 2023-11-30 | TARS | Wahl Bryan | GC | S - Sale+OE | $16.31 | -8,356 | 32.0K | -21% | -$136.3K |
| D | 2023-12-01 | 2023-11-30 | TARS | Whitfield Dianne C. | CHRO | S - Sale+OE | $16.31 | -8,355 | 26.8K | -24% | -$136.3K |
| D | 2023-12-01 | 2023-11-29 | TARS | Whitfield Dianne C. | CHRO | M - OptEx | $0.00 | +23.9K | 35.1K | +213% | $0 |
| MI | 2023-11-17 | 2023-11-15 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $18.37 | -8,000 | 883.2K | -0.9% | -$146.9K |
| I | 2023-10-20 | 2023-10-18 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $13.24 | -8,000 | 886.1K | -0.9% | -$105.9K |
| 2023-10-06 | 2023-10-05 | TARS | Trevejo Jose M. | Chief MEDICAL Off | S - Sale | $18.00 | -1,604 | 4,503 | -26% | -$28.9K | |
| I | 2023-09-22 | 2023-09-20 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $17.21 | -8,000 | 894.1K | -0.9% | -$137.7K |
| D | 2023-09-19 | 2023-09-15 | TARS | Morrison Scott W | Dir | M - OptEx | — | +1,333 | 1,333 | New | — |
| I | 2023-08-25 | 2023-08-23 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $17.23 | -8,000 | 902.1K | -0.9% | -$137.8K |
| I | 2023-08-17 | 2023-08-15 | TARS | Lin Elizabeth Yeu | Dir | P - Purchase | $16.80 | +9,506 | 15.9K | +149% | +$159.7K |
| MI | 2023-07-21 | 2023-07-19 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $20.01 | -103.9K | 910.1K | -10% | -$2.08M |
| 2023-07-21 | 2023-07-19 | TARS | Mottiwala Aziz | Chief Commercial Off | S - Sale | $20.05 | -2,400 | 45.8K | -5% | -$48.1K | |
| I | 2023-07-14 | 2023-07-12 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $17.35 | -9,000 | 1.01M | -0.9% | -$156.2K |
| I | 2023-06-23 | 2023-06-21 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $18.63 | -8,000 | 1.02M | -0.8% | -$149.0K |
| D | 2023-06-21 | 2023-06-16 | TARS | YARNO WENDY L | Dir | M - OptEx | — | +2,000 | 2,000 | New | — |
| D | 2023-06-21 | 2023-06-16 | TARS | Goldberg Andrew D. | Dir | M - OptEx | — | +2,000 | 2,000 | New | — |
| D | 2023-06-21 | 2023-06-16 | TARS | Crane Rosemary A | Dir | M - OptEx | — | +2,000 | 2,000 | New | — |
| D | 2023-06-21 | 2023-06-16 | TARS | CHAUDHURI BHASKAR | Dir | M - OptEx | — | +2,000 | 2,000 | New | — |
| D | 2023-06-21 | 2023-06-16 | TARS | LINK WILLIAM J PHD | Dir | M - OptEx | — | +2,000 | 136.6K | +1% | — |
| D | 2023-06-21 | 2023-06-16 | TARS | Lin Elizabeth Yeu | Dir | M - OptEx | — | +2,000 | 2,000 | New | — |
| I | 2023-06-16 | 2023-06-14 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $18.58 | -9,000 | 1.03M | -0.9% | -$167.2K |
| I | 2023-06-12 | 2023-06-08 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $20.01 | -3,100 | 1.04M | -0.3% | -$62.0K |
| 2023-06-12 | 2023-06-08 | TARS | Mottiwala Aziz | Chief Commercial Off | S - Sale | $20.00 | -100 | 48.1K | -0.2% | -$2,000 | |
| M | 2023-06-08 | 2023-06-06+ | TARS | Mottiwala Aziz | Chief Commercial Off | S - Sale | $19.00 | -4,643 | 50.7K | -8% | -$88.2K |
| I | 2023-05-19 | 2023-05-17 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $15.90 | -8,000 | 1.04M | -0.8% | -$127.2K |
| MI | 2023-05-15 | 2023-05-11 | TARS | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -174.4K | 109.9K | -61% | $0 |
| I | 2023-05-12 | 2023-05-10 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $16.80 | -9,000 | 1.05M | -0.8% | -$151.2K |
| MI | 2023-05-02 | 2023-04-28+ | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $15.11 | -10.1K | 1.06M | -0.9% | -$152.9K |
| I | 2023-04-25 | 2023-04-21 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $15.03 | -2,311 | 1.07M | -0.2% | -$34.7K |
| I | 2023-04-21 | 2023-04-19 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $13.60 | -8,000 | 1.07M | -0.7% | -$108.8K |
| 2023-04-21 | 2023-04-20 | TARS | Greenstein Leonard M. | CFO | S - Sale | $14.02 | -5,000 | 26.8K | -16% | -$70.1K | |
| M | 2023-03-23 | 2023-03-21+ | TARS | Mottiwala Aziz | Chief Commercial Off | S - Sale | $12.55 | -1,078 | 53.2K | -2% | -$13.5K |
| M | 2023-03-23 | 2023-03-21+ | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $12.55 | -2,125 | 8,597 | -20% | -$26.7K |
| M | 2023-03-23 | 2023-03-21+ | TARS | Greenstein Leonard M. | CFO | S - Sale | $12.55 | -1,004 | 31.8K | -3% | -$12.6K |
| M | 2023-03-23 | 2023-03-21+ | TARS | Neervannan Seshadri | COO | S - Sale | $12.55 | -1,141 | 55.5K | -2% | -$14.3K |
| M | 2023-03-23 | 2023-03-21+ | TARS | Trevejo Jose M. | Chief MEDICAL Off | S - Sale | $12.58 | -1,513 | 7,101 | -18% | -$19.0K |
| M | 2023-03-23 | 2023-03-21+ | TARS | Whitfield Dianne C. | CHRO | S - Sale | $12.55 | -1,004 | 11.6K | -8% | -$12.6K |
| M | 2023-03-23 | 2023-03-21+ | TARS | Wahl Bryan | GC | S - Sale | $12.55 | -1,078 | 16.8K | -6% | -$13.5K |
| M | 2023-03-21 | 2023-03-17+ | TARS | Wahl Bryan | GC | S - Sale | $12.94 | -696 | 17.8K | -4% | -$9,004 |
| M | 2023-03-21 | 2023-03-17+ | TARS | Greenstein Leonard M. | CFO | S - Sale | $12.94 | -649 | 32.8K | -2% | -$8,396 |
| M | 2023-03-21 | 2023-03-17+ | TARS | Whitfield Dianne C. | CHRO | S - Sale | $12.94 | -649 | 12.6K | -5% | -$8,396 |
| M | 2023-03-21 | 2023-03-17+ | TARS | Mottiwala Aziz | Chief Commercial Off | S - Sale | $12.94 | -697 | 54.3K | -1% | -$9,016 |
| M | 2023-03-21 | 2023-03-17+ | TARS | Holdbrook Mark J. | VP, Clinical Affairs | S - Sale | $12.94 | -386 | 3,389 | -10% | -$4,993 |
| M | 2023-03-21 | 2023-03-17+ | TARS | Trevejo Jose M. | Chief MEDICAL Off | S - Sale | $12.94 | -1,034 | 7,620 | -12% | -$13.4K |
| M | 2023-03-21 | 2023-03-17+ | TARS | Neervannan Seshadri | COO | S - Sale | $12.94 | -740 | 56.2K | -1% | -$9,573 |
| M | 2023-03-21 | 2023-03-17+ | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $12.96 | -1,536 | 11.5K | -12% | -$19.9K |
| MI | 2023-03-17 | 2023-03-15 | TARS | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -163.4K | 68.7K | -70% | $0 |
| D | 2023-03-17 | 2023-03-15 | TARS | Greenstein Leonard M. | CFO | M - OptEx | — | +4,462 | 38.8K | +13% | — |
| DM | 2023-03-17 | 2023-03-16 | TARS | Greenstein Leonard M. | CFO | S - Sale+OE | $13.44 | -5,313 | 33.4K | -14% | -$71.4K |
| D | 2023-03-17 | 2023-03-16 | TARS | Holdbrook Mark J. | VP, Clinical Affairs | S - Sale+OE | $13.43 | -187 | 3,577 | -5% | -$2,511 |
| D | 2023-03-17 | 2023-03-15 | TARS | Holdbrook Mark J. | VP, Clinical Affairs | M - OptEx | — | +2,653 | 3,764 | +239% | — |
| D | 2023-03-17 | 2023-03-16 | TARS | Mottiwala Aziz | Chief Commercial Off | S - Sale+OE | $13.43 | -336 | 54.6K | -0.6% | -$4,512 |
| D | 2023-03-17 | 2023-03-15 | TARS | Mottiwala Aziz | Chief Commercial Off | M - OptEx | — | +4,790 | 54.9K | +10% | — |
| D | 2023-03-17 | 2023-03-15 | TARS | Neervannan Seshadri | COO | M - OptEx | — | +5,097 | 56.9K | +10% | — |
| D | 2023-03-17 | 2023-03-16 | TARS | Neervannan Seshadri | COO | S - Sale+OE | $13.43 | -357 | 56.6K | -0.6% | -$4,795 |
| D | 2023-03-17 | 2023-03-16 | TARS | Wahl Bryan | GC | S - Sale+OE | $13.43 | -337 | 18.2K | -2% | -$4,526 |
| D | 2023-03-17 | 2023-03-15 | TARS | Wahl Bryan | GC | M - OptEx | — | +4,790 | 18.5K | +35% | — |
| D | 2023-03-17 | 2023-03-16 | TARS | Whitfield Dianne C. | CHRO | S - Sale+OE | $13.43 | -313 | 12.9K | -2% | -$4,204 |
| D | 2023-03-17 | 2023-03-15 | TARS | Whitfield Dianne C. | CHRO | M - OptEx | — | +4,462 | 13.2K | +51% | — |
| DI | 2023-03-17 | 2023-03-15 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale+OE | $13.79 | -8,000 | 1.08M | -0.7% | -$110.3K |
| D | 2023-03-17 | 2023-03-16 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale+OE | $13.43 | -791 | 12.3K | -6% | -$10.6K |
| D | 2023-03-17 | 2023-03-15 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | M - OptEx | — | +11.3K | 13.0K | +646% | — |
| D | 2023-03-17 | 2023-03-15 | TARS | Trevejo Jose M. | Chief Medical Off | M - OptEx | — | +7,549 | 9,153 | +471% | — |
| D | 2023-03-17 | 2023-03-16 | TARS | Trevejo Jose M. | Chief Medical Off | S - Sale+OE | $13.43 | -499 | 8,654 | -5% | -$6,702 |
| MI | 2023-03-10 | 2023-03-08+ | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $15.02 | -5,570 | 1.09M | -0.5% | -$83.7K |
| I | 2023-02-17 | 2023-02-15 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $15.28 | -8,000 | 1.09M | -0.7% | -$122.2K |
| 2023-02-17 | 2023-02-16 | TARS | Greenstein Leonard M. | CFO | S - Sale | $15.12 | -5,000 | 34.3K | -13% | -$75.6K | |
| I | 2023-02-10 | 2023-02-08 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $15.14 | -9,000 | 1.10M | -0.8% | -$136.3K |
| I | 2023-01-25 | 2023-01-23 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $15.45 | -4,856 | 1.11M | -0.4% | -$75.0K |
| I | 2023-01-24 | 2023-01-06 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $15.00 | -411 | 1.13M | -0.0% | -$6,165 |
| MI | 2023-01-20 | 2023-01-18+ | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $14.57 | -8,240 | 1.12M | -0.7% | -$120.1K |
| 2023-01-20 | 2023-01-19 | TARS | Greenstein Leonard M. | CFO | S - Sale | $14.56 | -5,000 | 39.3K | -11% | -$72.8K | |
| I | 2023-01-13 | 2023-01-11 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $15.11 | -3,904 | 1.12M | -0.3% | -$59.0K |
| MI | 2023-01-11 | 2023-01-09+ | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $15.16 | -1,634 | 1.13M | -0.1% | -$24.8K |
| I | 2022-12-22 | 2022-12-21 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $14.57 | -8,000 | 1.13M | -0.7% | -$116.6K |
| I | 2022-12-20 | 2022-12-16 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $15.01 | -535 | 1.14M | -0.0% | -$8,030 |
| I | 2022-12-16 | 2022-12-14 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $15.08 | -6,420 | 1.14M | -0.6% | -$96.8K |
| 2022-12-16 | 2022-12-15 | TARS | Greenstein Leonard M. | CFO | S - Sale | $14.64 | -5,000 | 44.3K | -10% | -$73.2K | |
| 2022-12-06 | 2022-12-02 | TARS | Wahl Bryan | GC | S - Sale | $16.90 | -1,154 | 13.7K | -8% | -$19.5K | |
| 2022-12-06 | 2022-12-02 | TARS | Whitfield Dianne C. | CHRO | S - Sale | $16.90 | -1,154 | 8,723 | -12% | -$19.5K | |
| DM | 2022-12-01 | 2022-11-30+ | TARS | Whitfield Dianne C. | CHRO | S - Sale+OE | $16.62 | -2,347 | 9,877 | -19% | -$39.0K |
| D | 2022-12-01 | 2022-11-29 | TARS | Whitfield Dianne C. | CHRO | M - OptEx | $0.00 | +10.3K | 12.2K | +520% | $0 |
| DM | 2022-12-01 | 2022-11-30+ | TARS | Wahl Bryan | GC | S - Sale+OE | $16.62 | -2,347 | 14.9K | -14% | -$39.0K |
| D | 2022-12-01 | 2022-11-29 | TARS | Wahl Bryan | GC | M - OptEx | $0.00 | +10.3K | 17.2K | +147% | $0 |
| MI | 2022-11-18 | 2022-11-16 | TARS | Azamian Bobak R. | Pres, CEO, Dir | S - Sale | $16.86 | -8,000 | 1.15M | -0.7% | -$134.9K |
| 2022-11-18 | 2022-11-17 | TARS | Greenstein Leonard M. | CFO | S - Sale | $16.54 | -5,000 | 49.3K | -9% | -$82.7K | |
| 2022-11-17 | 2022-11-15 | TARS | Mottiwala Aziz | Chief Commercial Off | S - Sale | $17.72 | -6,857 | 49.7K | -12% | -$121.5K | |
| MI | 2022-11-14 | 2022-11-10 | TARS | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -207.2K | 16.5K | -93% | $0 |
| I | 2022-11-14 | 2022-11-09 | TARS | Azamian Bobak R. | Pres, CEO, Dir | S - Sale | $17.87 | -9,000 | 1.15M | -0.8% | -$160.8K |
| M | 2022-10-28 | 2022-10-20 | TARS | Greenstein Leonard M. | CFO | S - Sale | $15.92 | -5,000 | 54.4K | -8% | -$79.6K |
Purchase Sale Sale after option exercise All abbreviations